Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.

Carriers of mutations in hereditary cancer predisposition genes represent a small but clinically important subgroup of oncology patients. The identification of causal germline mutations determines follow-up management, treatment options and genetic counselling in patients' families. Targeted ne...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jana Soukupova, Petra Zemankova, Klara Lhotova, Marketa Janatova, Marianna Borecka, Lenka Stolarova, Filip Lhota, Lenka Foretova, Eva Machackova, Viktor Stranecky, Spiros Tavandzis, Petra Kleiblova, Michal Vocka, Hana Hartmannova, Katerina Hodanova, Stanislav Kmoch, Zdenek Kleibl
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science (PLoS) 2018-01-01
Серии:PLoS ONE
Online-ссылка:http://europepmc.org/articles/PMC5896995?pdf=render
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы